These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SOX6 Expression Is Sensitive for Peritoneal Epithelioid Malignant Mesothelioma, But Not Specific in the Differential Diagnosis With Tubo-ovarian Serous Neoplasia. Chapel DB, Hirsch MS. Am J Surg Pathol; 2022 Feb 01; 46(2):213-219. PubMed ID: 34411029 [Abstract] [Full Text] [Related]
4. BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations. Sheffield BS, Hwang HC, Lee AF, Thompson K, Rodriguez S, Tse CH, Gown AM, Churg A. Am J Surg Pathol; 2015 Jul 01; 39(7):977-82. PubMed ID: 25634745 [Abstract] [Full Text] [Related]
5. The diagnostic role of BAP1 in serous effusions. Davidson B, Tötsch M, Wohlschlaeger J, Hager T, Pinamonti M. Hum Pathol; 2018 Sep 01; 79():122-126. PubMed ID: 29802871 [Abstract] [Full Text] [Related]
7. Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens. Hwang HC, Sheffield BS, Rodriguez S, Thompson K, Tse CH, Gown AM, Churg A. Am J Surg Pathol; 2016 Jan 01; 40(1):120-6. PubMed ID: 26448191 [Abstract] [Full Text] [Related]
8. Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study. Xing D, Banet N, Sharma R, Vang R, Ronnett BM, Illei PB. Hum Pathol; 2018 Feb 01; 72():160-166. PubMed ID: 29241740 [Abstract] [Full Text] [Related]
10. BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas. Hwang HC, Pyott S, Rodriguez S, Cindric A, Carr A, Michelsen C, Thompson K, Tse CH, Gown AM, Churg A. Am J Surg Pathol; 2016 May 01; 40(5):714-8. PubMed ID: 26900815 [Abstract] [Full Text] [Related]
11. New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet? Churg A, Sheffield BS, Galateau-Salle F. Arch Pathol Lab Med; 2016 Apr 01; 140(4):318-21. PubMed ID: 26288396 [Abstract] [Full Text] [Related]
15. BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma. Devins KM, Zukerberg L, Watkins JC, Hung YP, Oliva E. Int J Gynecol Pathol; 2023 Mar 01; 42(2):159-166. PubMed ID: 35512220 [Abstract] [Full Text] [Related]
17. BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma. McGregor SM, McElherne J, Minor A, Keller-Ramey J, Dunning R, Husain AN, Vigneswaran W, Fitzpatrick C, Krausz T. Hum Pathol; 2017 Feb 01; 60():86-94. PubMed ID: 27771374 [Abstract] [Full Text] [Related]
18. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Histopathology; 2002 Mar 01; 40(3):237-44. PubMed ID: 11895489 [Abstract] [Full Text] [Related]
19. BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests. Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, Kawahara K, Iwasaki A, Okamoto T, Oda Y, Honda H, Nabeshima K. Pathol Int; 2016 Oct 01; 66(10):563-570. PubMed ID: 27614970 [Abstract] [Full Text] [Related]
20. Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer. Owen D, Sheffield BS, Ionescu D, Churg A. Hum Pathol; 2017 Feb 01; 60():82-85. PubMed ID: 27984124 [Abstract] [Full Text] [Related] Page: [Next] [New Search]